Latest News

Gilead to Launch Authorized Generic Versions of Hepatitis C Treatments
Officials with Gilead Sciences, Inc. plan to launch authorized generic versions of Epclusa and Harvoni.
The US Preventive Services Task Force recommends against routine screening for prostate cancer in men 70 years of age and older.
In this clip, Gordon Vanscoy, PharmD, MBA, CEO of PANTHERx Specialty Pharmacy, explains how orphan drugs are making an impact on patients in the era of precision medicine.
Financial modeling tool shows research and development lacking of new vaccine candidates for HIV, tuberculosis, and malaria.
By mapping out the epigenomic landscape of rheumatoid arthritis, scientists hope to gain insight on disease origins as well as new cell signaling pathways.
Officials with the FDA have approved duvelisib (Copiktra) for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) or relapsed/refractory follicular lymphoma.
A mobile app technology used to identify and track symptom relief helped measure real-time cannabis use.
In this video, Gordon Vanscoy, PharmD, MBA, CEO of PANTHERx, describes the methods of patient support used by PantheRx throughout treatment to provide optimal care.

Features

With American Patients First, the administration is doing its part to improve prescription drug affordability—now it’s time for Congress to do theirs.
As specialty spending continues to creep up to 50% of total drug spend, payers have an option to directly reduce their costs while impacting a relatively small volume of prescriptions.
By establishing in-house specialty pharmacies, health systems can accelerate growth while offering patients innovative therapies, an enhanced experience, and clinically coordinated care that ultimately improves outcomes.
There has been increasing buzz surrounding health care reform concepts that which seek to address the singular issue of individual health care coverage affordability.

Featured Company Profile

 
MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy

Videos

In this clip, Gordon Vanscoy, PharmD, MBA, CEO of PANTHERx Specialty Pharmacy, explains how orphan drugs are making an impact on patients in the era of precision medicine.

In this video, Gordon Vanscoy, PharmD, MBA, CEO of PANTHERx, describes the methods of patient support used by PantheRx throughout treatment to provide optimal care.

Brandon Newman, PharmD, CSP, Program Director, Vanderbilt Specialty Pharmacy, talks about why pharmacists should pursue continuing education to benefit their patients.

Current Issue

September/October
Volume: 9
Number: 6

Most Popular

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$